Literature DB >> 14500810

Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-alpha gene transcription by Pax-5 (BSAP).

Holly Maier1, Rachel Ostraat, Sarah Parenti, Daniel Fitzsimmons, Lawrence J Abraham, Colin W Garvie, James Hagman.   

Abstract

Pax-5, a member of the paired domain family of transcription factors, is a key regulator of B lymphocyte-specific transcription and differentiation. A major target of Pax-5-mediated activation is the mb-1 gene, which encodes the essential transmembrane signaling protein Ig-alpha. Pax-5 recruits three members of the Ets family of transcription factors: Ets-1, Fli-1 and GABPalpha (with GABPbeta1), to assemble ternary complexes on the mb-1 promoter in vitro. Using the Pax-5:Ets-1:DNA crystal structure as a guide, we defined amino acid requirements for transcriptional activation of endogenous mb-1 genes using a novel cell-based assay. Mutations in the beta-hairpin/beta-turn of the DNA-binding domain of Pax-5 demonstrated its importance for DNA sequence recognition and activation of mb-1 transcription. Mutations of amino acids contacting Ets-1 in the crystal structure reduced or blocked mb-1 promoter activation. One of these mutations, Q22A, resulted in greatly reduced mb-1 gene transcript levels, concurrent with the loss of its ability to recruit Fli-1 to bind the promoter in vitro. In contrast, the mutation had no effect on recruitment of the related Ets protein GABPalpha (with GABPbeta1). These data further define requirements for Pax-5 function in vivo and reveal the complexity of interactions required for cooperative partnerships between transcription factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500810      PMCID: PMC206479          DOI: 10.1093/nar/gkg785

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

Review 1.  Molecular biology of the Ets family of transcription factors.

Authors:  Tsuneyuki Oikawa; Toshiyuki Yamada
Journal:  Gene       Date:  2003-01-16       Impact factor: 3.688

2.  Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2.

Authors:  M Tassabehji; A P Read; V E Newton; M Patton; P Gruss; R Harris; T Strachan
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

3.  DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site.

Authors:  T Czerny; G Schaffner; M Busslinger
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

4.  The splotch-delayed (Spd) mouse mutant carries a point mutation within the paired box of the Pax-3 gene.

Authors:  K J Vogan; D J Epstein; D G Trasler; P Gros
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

5.  undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax 1.

Authors:  R Balling; U Deutsch; P Gruss
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

6.  Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.

Authors:  Mikael Sigvardsson; Dawn R Clark; Daniel Fitzsimmons; Michelle Doyle; Peter Akerblad; Thomas Breslin; Sven Bilke; Ronggui Li; Carmen Yeamans; Gongyi Zhang; James Hagman
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

7.  Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex.

Authors:  C C Thompson; T A Brown; S L McKnight
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

8.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.

Authors:  B Adams; P Dörfler; A Aguzzi; Z Kozmik; P Urbánek; I Maurer-Fogy; M Busslinger
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

9.  Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.

Authors:  J L Bennicelli; W J Fredericks; R B Wilson; F J Rauscher; F G Barr
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

10.  Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP.

Authors:  P Urbánek; Z Q Wang; I Fetka; E F Wagner; M Busslinger
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

View more
  19 in total

1.  Bivalent recognition of nucleosomes by the tandem PHD fingers of the CHD4 ATPase is required for CHD4-mediated repression.

Authors:  Catherine A Musselman; Julita Ramírez; Jennifer K Sims; Robyn E Mansfield; Samuel S Oliver; John M Denu; Joel P Mackay; Paul A Wade; James Hagman; Tatiana G Kutateladze
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-03       Impact factor: 11.205

2.  Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1.

Authors:  Omar Moussa; Amanda C LaRue; Romeo S Abangan; Christopher R Williams; Xian K Zhang; Masahiro Masuya; Yong Z Gong; Demetri D Spyropoulos; Makio Ogawa; Gary Gilkeson; Dennis K Watson
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

3.  Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors.

Authors:  Peter C Hollenhorst; David A Jones; Barbara J Graves
Journal:  Nucleic Acids Res       Date:  2004-10-21       Impact factor: 16.971

4.  A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis.

Authors:  Sarah Bradshaw; W Jim Zheng; Lam C Tsoi; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2008-08-09       Impact factor: 3.969

5.  A strong promoter activity of pre-B cell stage-specific Crlz1 gene is caused by one distal LEF-1 and multiple proximal Ets sites.

Authors:  Sung-Kyun Park; Youngsook Son; Chang-Joong Kang
Journal:  Mol Cells       Date:  2011-05-02       Impact factor: 5.034

6.  A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.

Authors:  Sohela Shah; Kasmintan A Schrader; Esmé Waanders; Andrew E Timms; Joseph Vijai; Cornelius Miething; John T Sandlund; Marshall S Horwitz; Charles G Mullighan; Kenneth Offit; Jeremy Wechsler; Jun Yang; James Hayes; Robert J Klein; Jinghui Zhang; Lei Wei; Gang Wu; Michael Rusch; Panduka Nagahawatte; Jing Ma; Shann-Ching Chen; Guangchun Song; Jinjun Cheng; Paul Meyers; Deepa Bhojwani; Suresh Jhanwar; Peter Maslak; Martin Fleisher; Jason Littman; Lily Offit; Rohini Rau-Murthy; Megan Harlan Fleischut; Marina Corines; Rajmohan Murali; Xiaoni Gao; Christopher Manschreck; Thomas Kitzing; Vundavalli V Murty; Susana Raimondi; Roland P Kuiper; Annet Simons; Joshua D Schiffman; Kenan Onel; Sharon E Plon; David Wheeler; Deborah Ritter; David S Ziegler; Kathy Tucker; Rosemary Sutton; Georgia Chenevix-Trench; Jun Li; David G Huntsman; Samantha Hansford; Janine Senz; Thomas Walsh; Ming Lee; Christopher N Hahn; Kathryn Roberts; Mary-Claire King; Sarah M Lo; Ross L Levine; Agnes Viale; Nicholas D Socci; Katherine L Nathanson; Hamish S Scott; Mark Daly; Steven M Lipkin; Scott W Lowe; James R Downing; David Altshuler
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

7.  The mouse B cell-specific mb-1 gene encodes an immunoreceptor tyrosine-based activation motif (ITAM) protein that may be evolutionarily conserved in diverse species by purifying selection.

Authors:  Richard Sims; Virginia Oberholzer Vandergon; Cindy S Malone
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

8.  Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5.

Authors:  Daniel Fitzsimmons; Kara Lukin; Ryan Lutz; Colin W Garvie; Cynthia Wolberger; James Hagman
Journal:  J Mol Biol       Date:  2009-07-17       Impact factor: 5.469

9.  The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis.

Authors:  Meiqin Wang; Julita Ramirez; Junyan Han; Yi Jia; Joanne Domenico; Max A Seibold; James R Hagman; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2013-07-16       Impact factor: 10.793

10.  Targeting the GA binding protein beta1L isoform does not perturb lymphocyte development and function.

Authors:  Hai-Hui Xue; Xuefang Jing; Julie Bollenbacher-Reilley; Dong-Mei Zhao; Jodie S Haring; Baoli Yang; Chengyu Liu; Gail A Bishop; John T Harty; Warren J Leonard
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.